KALV vs AMGN: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Amgen Inc in 2026
KALV
Kalvista Pharmaceuticals Inc
$20.48
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | KALV | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.00B | $188.34B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.22 | AMGN |
| Revenue Growth | 0.3% | 0.1% | KALV |
| Gross Margin | 25.7% | 70.8% | AMGN |
Analyze KALV
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or AMGN a better investment?
Comparing KALV and AMGN: Kalvista Pharmaceuticals Inc has a market cap of $1.00B while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and AMGN?
KALV (Kalvista Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or AMGN?
KALV has higher revenue growth at 0.3% vs 0.1% for AMGN.
Which company is more profitable: KALV or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 25.7% for KALV.
Which is the larger company: KALV or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $1.00B for KALV.
Should I buy KALV or AMGN in 2026?
Both KALV and AMGN have investment merit. KALV trades at $20.48 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and AMGN stock?
Key differences: Market Cap ($1.00B vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.3% vs 0.1%), Gross Margin (25.7% vs 70.8%).